Bacterial spectrum analysis and antimicrobial susceptibility study of osteoradionecrosis of the jaw in Southern China

Oral Diseases ◽  
2021 ◽  
Author(s):  
Yue Zhu ◽  
Jianfeng Liang ◽  
Fang Wang ◽  
Jiaxin Li ◽  
Cheng Wang ◽  
...  

Author(s):  
María Jesús Castaño Aroca ◽  
Beatriz Acosta Boga ◽  
Noelia Lozano Rodríguez ◽  
Rabab Chouman Arcas


2018 ◽  
Vol 62 (12) ◽  
Author(s):  
Jason R. Barash ◽  
Joe B. Castles ◽  
Stephen S. Arnon

ABSTRACTInfant botulism is an infectious intestinal toxemia that results from colonization of the infant large bowel byClostridium botulinum(or rarely, by neurotoxigenicClostridium baratiiorClostridium butyricum), with subsequent intraintestinal production and absorption of botulinum neurotoxin that then produces flaccid paralysis. The disease is often initially misdiagnosed as suspected sepsis or meningitis, diagnoses that require prompt empirical antimicrobial therapy. Antibiotics may also be needed to treat infectious complications of infant botulism, such as pneumonia or urinary tract infection. Clinical evidence suggests (see case report below) that broad-spectrum antibiotics that are eliminated by biliary excretion may cause progression of the patient’s paralysis by lysingC. botulinumvegetative cells in the large bowel lumen, thereby increasing the amount of botulinum neurotoxin available for absorption. The purpose of this antimicrobial susceptibility study was to identify an antimicrobial agent with little or no activity againstC. botulinumthat could be used to treat infant botulism patients initially diagnosed with suspected sepsis or meningitis, or who acquired secondary infections, without lysingC. botulinum. Testing of 12 antimicrobial agents indicated that almost all California infant botulism patient isolates are susceptible to most clinically utilized antibiotics and are also susceptible to newer antibiotics not previously tested against large numbers ofC. botulinumpatient isolates. No antibiotic with little or no activity againstC. botulinumwas identified. These findings reinforce the importance of promptly treating infant botulism patients with human botulism immune globulin (BIG-IV [BabyBIG]).



2019 ◽  
Vol 16 (2) ◽  
pp. 185-192 ◽  
Author(s):  
Jiao-Sheng Zhang ◽  
Hong-Mei Wang ◽  
Kai-Hu Yao ◽  
Ying Liu ◽  
Yan-Ling Lei ◽  
...  


2011 ◽  
Vol 5 (12) ◽  
pp. 1374-1378 ◽  
Author(s):  
Patel H ◽  
Shah A ◽  
Mistry M ◽  
Ch S ◽  
a


Urology ◽  
2015 ◽  
Vol 86 (3) ◽  
pp. 492-497 ◽  
Author(s):  
Marcelo Hisano ◽  
Homero Bruschini ◽  
Antonio Carlos Nicodemo ◽  
Cristiano Mendes Gomes ◽  
Marcos Lucon ◽  
...  


2014 ◽  
Vol 39 (11) ◽  
pp. 1069-1075 ◽  
Author(s):  
Verena Prokosch ◽  
Jan-Erik Prokosch ◽  
Julia Promesberger ◽  
Evgeny A. Idelevich ◽  
Michael R. R. Böhm ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document